The Merck Group Website
The Merck Group Website

Pergoveris™ (r-hFSH 150IU and r-hLH 75IU)

Pergoveris™ (r-hFSH 150IU and r-hLH 75IU) is a combination of follitropin alfa (r-hFSH) and lutropin alfa (r-hLH). Pergoveris is indicated for the stimulation of follicular development in women with severe LH and FSH deficiency.

The information contained in these pages is intended for general reference only. It may refer to pharmaceutical products, therapeutics or indications not yet registered or approved in a given country. This information should not be used to diagnose, treat, cure or prevent any disease without the advice of a qualified medical professional, and does not replace medical advice or a medical examination.

US Residents should consult EMD Serono, Inc. for information on products approved for sale in the United States of America.